ArticleViruses2024
African Swine Fever in Saxony-Disease Dynamics.
Article in Viruses, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Modelling African Swine Fever Transmission and Epidemiology: A Scoping Review of Mechanistic, Statistical, and Machine Learning Approaches.Tropical medicine and infectious disease · 2026Review
- Duration of immunity following infection with moderately virulent ASFV.PLoS pathogens · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
African swine fever (ASF) emerged in Germany in 2020. A few weeks after the initial occurrence, infected wild boar were detected in Saxony. In this study, data from wild boar surveillance in Saxony were analyzed. The analysis focused on the eastern districts of the state, where the disease likely spread through infected wild boar. Additionally, data from Meissen, located approximately 65 km further west, were examined. In Meissen, the disease emerged one year later, and a human-mediated introduction was suspected. To evaluate the progression of ASF in the two study areas over time, data from active and passive surveillance were analyzed both descriptively and using a Bayesian space-time model. Prevalence estimates were calculated for wild boar testing positive for the ASF virus and for ASF-specific antibodies. Higher prevalence estimates were observed in the eastern districts, indicating a stronger viral load, consistent with patterns seen in other European regions. Over time, seroprevalence increased, suggesting an accumulation of surviving wild boar. The findings provide important insights into the epidemiology of ASF in wild boar over time. They complement the existing knowledge and support targeted ASF control measures. This is particularly significant, as ASF continues to spread across Europe rather than being successfully eradicated.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.